{"url_path":"/sec/pure/8-k/2026-06-15/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-028686-index.html","accession_number":"0001493152-26-028686","cik":"0001006028","ticker":"PURE","issuer_name":"PURE BIOSCIENCE, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006028/0001493152-26-028686-index.html","primary_entity_key":"0001006028","primary_entity_name":"PURE BIOSCIENCE, INC."},"word_count":110,"has_tables":true,"body_markdown":"**Item\n2.02. Results of Operations and Financial Condition.**\n\n \n\nOn\nJune 15, 2026, PURE Bioscience, Inc. (the “Company”) issued a press release announcing financial results for the fiscal third\nquarter ended April 30, 2026 and related information. A copy of the press release is attached as Exhibit 99.1.\n\n \n\nThe\ninformation in this Item 2.02 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities\nExchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Item 2.02 shall not be incorporated\nby reference into any registration statement or other document filed with the Securities and Exchange Commission."}